Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
RNA interference: a practical approach.
Duxbury MS, Whang EE. Duxbury MS, et al. J Surg Res. 2004 Apr;117(2):339-44. doi: 10.1016/j.jss.2003.09.010. J Surg Res. 2004. PMID: 15047140 Review.
RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Duxbury MS, et al. Clin Cancer Res. 2005 May 1;11(9):3433-8. doi: 10.1158/1078-0432.CCR-04-1510. Clin Cancer Res. 2005. PMID: 15867245 Free PMC article.
RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells.
Duxbury MS, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2005 Jun 3;331(2):459-63. doi: 10.1016/j.bbrc.2005.03.199. Biochem Biophys Res Commun. 2005. PMID: 15850781
Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Ann Surg. 2004 Oct;240(4):667-74; discussion 675-6. doi: 10.1097/01.sla.0000140755.97224.9a. Ann Surg. 2004. PMID: 15383794 Free PMC article.
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.
Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Surgery. 2004 Aug;136(2):261-9. doi: 10.1016/j.surg.2004.04.029. Surgery. 2004. PMID: 15300189
siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. J Am Coll Surg. 2004 Jun;198(6):953-9. doi: 10.1016/j.jamcollsurg.2004.01.037. J Am Coll Surg. 2004. PMID: 15194078
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Duxbury MS, et al. Cancer Res. 2004 Jun 1;64(11):3987-93. doi: 10.1158/0008-5472.CAN-04-0424. Cancer Res. 2004. PMID: 15173012
c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
Duxbury MS, Ito H, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2004 Apr 23;317(1):133-41. doi: 10.1016/j.bbrc.2004.03.018. Biochem Biophys Res Commun. 2004. PMID: 15047158
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Feb 19;23(7):1448-56. doi: 10.1038/sj.onc.1207247. Oncogene. 2004. PMID: 14973554
CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Jan 15;23(2):465-73. doi: 10.1038/sj.onc.1207036. Oncogene. 2004. PMID: 14724575
34 results
Jump to page
Feedback